Home Organizations Daewoong Pharmaceutical Co. LTD.
Registry trials: Daewoong Pharmaceutical Co. LTD. 18 registry trials linked to Daewoong Pharmaceutical Co. LTD. with phase phase 3, of 31, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 3 Not yet recruiting Planned start 2026-06 510 planned NCT07619833
Phase 3 Completed Started 2025-02-24 198 enrolled NCT06671392
Phase 3 Completed Started 2025-01-20 192 enrolled NCT06682000
Phase 3 Unknown status Planned start 2023-12 134 planned NCT06141980
Phase 3 Active, not recruiting Started 2023-10-25 541 enrolled NCT06027307
Phase 3 Unknown status Started 2023-03-17 240 planned NCT05466643
Phase 3 Completed Started 2023-02-23 214 enrolled NCT05643508
Phase 3 Unknown status Started 2022-09-28 340 enrolled NCT05505994
Phase 3 Completed Started 2021-05-25 159 enrolled NCT05376969
Phase 3 Unknown status Planned start 2021-02 280 planned NCT04772443
Phase 3 Completed Started 2020-12-30 270 enrolled NCT04654390
Phase 3 Completed Started 2020-11-18 200 enrolled NCT04634500
Phase 3 Completed Started 2020-11-11 140 enrolled NCT04632862
Phase 3 Unknown status Planned start 2019-11-20 237 planned NCT04161001
Phase 3 Completed Started 2017-01 265 enrolled NCT03009487
Phase 3 Completed Start date 2015-08 185 enrolled NCT02947620
Phase 3 Completed Start date 2013-09 197 enrolled NCT01945684
Phase 3 Completed Start date 2012-09 150 planned NCT01764295